SpineCor® has been designed for the treatment of idiopathic Scoliosis only. Its efficacy for treating neuromuscular, neurological or other types of scoliosis is unknown and generally non-idiopathic scoliosis is contraindicated.
- Idiopathic Scoliosis diagnosed and confirmed.
- Boy or Girl from 5 years of age +.
- Initial Cobb angle equal or above 15°, proven progression of more than 5° in last 6 months or strong family history.
- Initial Cobb angle equal or below 50°.
- Risser 0, 1, 2, 3 or pre-menarchial.
- Curve Types: All classes including curves that are inverse to normal patterns (e.g. Left Thoracic, Right Lumbar)
- Scoliosis resulting from a deficit of the neuromuscular system E.g.;
- Cerebral Palsy
- Traumatic paraplegia or quadriplegia
- Spinal Muscular Atrophy
- Friedreich’s Ataxia
- Familial Dysautonomia
- Peroneal Muscular Atrophy
- Postural Scoliosis: when a supine X-ray compares with a frontal X-ray shows an almost complete reduction (Cobb angle less than 5°).
- Patients who have had previous treatment except for Physiotherapy or shoe lift.
- In some cases SpineCor has shown to be effective after rigid braces,- only if the rigid brace has been worn for less than 6 months and the neuro-muscular system is not significantly affected.
- Patient compliance also needs to be considered. Your doctor or specialist treatment provider will need to carry out a comprehensive assessment before advising on suitability of SpineCor® treatment after rigid bracing.
- Patients with congenital defects.
Any patients treated outside the above indications must be considered experimental and informed consent obtained from patients. Out of indication treatments are the responsibility of the prescribing doctor; The SpineCorporation Limited cannot accept any responsibility for such treatments.